Prevalence of dementia, heart disease and stroke in community-dwelling adults in Canada, 2016–2021: opportunities for joint prevention
暂无分享,去创建一个
[1] C. D’Arcy,et al. Trends in prevalence of self-reports of Alzheimer’s disease/dementia among non-institutionalized individuals 45+ in Canada, 1994–2014 , 2022, Journal of public health research.
[2] V. Hachinski,et al. From Dementia to Eumentia: A New Approach to Dementia Prevention , 2022, Neuroepidemiology.
[3] B. Tang,et al. Regional and socioeconomic disparities in cardiovascular disease in Canada during 2005–2016: evidence from repeated nationwide cross-sectional surveys , 2021, BMJ Global Health.
[4] V. Hachinski,et al. Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 2017 , 2021, Neurological Sciences.
[5] V. Hachinski. Brain Health—Curbing Stroke, Heart Disease, and Dementia , 2021, Neurology.
[6] Aging People, Aging Places , 2021 .
[7] Release notice - Aging and Chronic Diseases: A Profile of Canadian Seniors. , 2021, Health promotion and chronic disease prevention in Canada : research, policy and practice.
[8] Maxwell Hartt,et al. Aging-in-place and the spatial distribution of older adult vulnerability in Canada , 2020 .
[9] D. Zaccaria,et al. Estimating the potential for dementia prevention through modifiable risk factors elimination in the real-world setting: a population-based study , 2020, Alzheimer's Research & Therapy.
[10] D. Seitz,et al. Trends of Dementia among Community-Dwelling Adults in Ontario, Canada, 2010–2015 , 2020, Dementia and Geriatric Cognitive Disorders.
[11] M. Hill,et al. Recent Trends in Hospitalizations for Cardiovascular Disease, Stroke, and Vascular Cognitive Impairment in Canada. , 2020, The Canadian journal of cardiology.
[12] G. Rudge,et al. Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK , 2020, Heart.
[13] R. Zhao,et al. The Urgent Need for International Action for Anti-aging and Disease Prevention , 2020, Aging and disease.
[14] Fabio Fierini. Mixed dementia: Neglected clinical entity or nosographic artifice? , 2019, Journal of the Neurological Sciences.
[15] S. Black,et al. Preventing dementia by preventing stroke: The Berlin Manifesto , 2019, Alzheimer's & Dementia.
[16] R. Stewart,et al. Post stroke depression and risk of stroke recurrence and mortality: A systematic review and meta-analysis , 2019, Ageing Research Reviews.
[17] A. Hofman,et al. Coronary heart disease, heart failure, and the risk of dementia: A systematic review and meta-analysis , 2018, Alzheimer's & Dementia.
[18] G. Agarwal,et al. Evaluation of a community paramedicine health promotion and lifestyle risk assessment program for older adults who live in social housing: a cluster randomized trial , 2018, Canadian Medical Association Journal.
[19] D. Manuel,et al. Transitions to long-term and residential care among older Canadians. , 2018, Health reports.
[20] J. Metsemakers,et al. Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands , 2017, The European journal of general practice.
[21] Guy M. McKhann,et al. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort , 2017, JAMA neurology.
[22] M. Kivimäki,et al. Atrial fibrillation as a risk factor for cognitive decline and dementia , 2017, European heart journal.
[23] S. Pocock,et al. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial , 2017, PloS one.
[24] Karen Tu,et al. Alzheimer’s and other dementias in Canada, 2011 to 2031: a microsimulation Population Health Modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use , 2016, Population Health Metrics.
[25] S. Stewart,et al. A systematic review and meta-analysis of primary prevention programmes to improve cardio-metabolic risk in non-urban communities. , 2016, Preventive medicine.
[26] Suzy L. Wong,et al. Alzheimer's disease and other dementias in Canada. , 2016, Health reports.
[27] Katherine Ludwin. Women and Dementia: All But Forgotten? A literature review , 2015 .
[28] M. Pinter,et al. Prevention of Poststroke Cognitive Decline: ASPIS – a Multicenter, Randomized, Observer-Blind, Parallel Group Clinical Trial to Evaluate Multiple Lifestyle Interventions – Study Design and Baseline Characteristics , 2015, International journal of stroke : official journal of the International Stroke Society.
[29] O. Franco,et al. Subclinical cardiac dysfunction increases the risk of stroke and dementia , 2015, Neurology.
[30] S. Bamford,et al. Women and dementia--not forgotten. , 2012, Maturitas.
[31] Rowena J Dolor,et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.
[32] C. Bulpitt,et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.
[33] K. Black. Health and Aging-in-Place: Implications for Community Practice , 2008 .
[34] Constance K Haan,et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[35] A. Hanks. Canada , 2002 .
[36] P. Whelton,et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.
[37] M. Mielke. Sex and Gender Differences in Alzheimer's Disease Dementia. , 2018, The Psychiatric times.
[38] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..